Current Journal of Neurology, published by Tehran University of Medical Sciences, is an esteemed Open Access journal dedicated to advancing the field of neurology. Since its inception in 2011, the journal has provided a platform for innovative research and critical discourse in neurology and clinical neurology, with a focus on the latest advancements and methodologies. Although the journal currently holds a Q4 quartile ranking in both neurology and clinical neurology, its goal is to foster the global dissemination of knowledge and ideas relevant to the complexities of neurological disorders. Researchers, professionals, and students exploring this dynamic field will find valuable insights, as the journal aims to bridge the gap between emerging research and clinical application. Based in Tehran, Iran, the Current Journal of Neurology welcomes contributions that enhance understanding and treatment of neurological conditions, thereby promoting evidence-based practices across the globe.

Annals of Clinical and Translational Neurology is a premier journal published by WILEY, focusing on the fields of neurology and neuroscience. Since its inception in 2014, it has established itself as an Open Access platform, providing unrestricted access to cutting-edge research to promote scientific collaboration and innovation. With an impressive Impact Factor residing in the top quartile (Q1) for both clinical neurology and miscellaneous neuroscience in 2023, this journal ranks #52 out of 400 in the Neurology category and #22 out of 113 in General Neuroscience, indicating its significant contribution to the field. The journal welcomes submissions that address emerging trends and challenges in translational neurology, aiming to bridge the gap between laboratory research and clinical practice. By disseminating high-quality research and fostering a community of scholars, Annals of Clinical and Translational Neurology plays a vital role in advancing our understanding of neurological disorders and improving patient care worldwide.

Case Reports in Neurology is a distinguished open-access journal published by KARGER, dedicated to the advancement of knowledge in the field of neurology. Since its inception in 2009, the journal has provided a vital platform for the dissemination of clinical case reports, enhancing the understanding of various neurological disorders and their management. With an ISSN of 1662-680X, it is indexed in Scopus, ranking #295 out of 400 in the neurology (clinical) category for 2023, placing it in the 26th percentile. The journal welcomes contributions from researchers, clinicians, and students alike, offering insights into unique cases and treatment outcomes that can significantly impact clinical practice. Located in Basel, Switzerland, the journal emphasizes the importance of sharing exceptional clinical experiences that can inform future research and evidence-based practices. By promoting open access, Case Reports in Neurology ensures that valuable information is available to the global medical community, further bridging gaps in neurology research and clinical application.

Neurology Asia is a prestigious peer-reviewed journal dedicated to advancing the field of neurology in the Asia-Pacific region. Published by the ASEAN NEUROLOGICAL ASSOCIATION, this journal serves as a vital platform for sharing innovative research and clinical practices among neurologists and neuroscientists. With an ISSN of 1823-6138, it encompasses a broad range of topics within the realm of neurology and clinical neurology, allowing for an expansive dialogue on neurological disorders, treatments, and advancements in medical science. Although currently positioned in the Q4 quartile of both neurology and clinical neurology categories, it is committed to enhancing its reputation and impact within the academic community. While the journal is not an open-access publication, it strives to provide authors a respectable outlet for disseminating critical research findings. The journal’s address, located at the UNIV MALAYA MEDICAL CENTRE in Kuala Lumpur, Malaysia, reflects its commitment to fostering regional advancements in neurological research. By engaging with Neurology Asia, researchers, professionals, and students will contribute to shaping the future of neurology across Asia.

Welcome to the Journal of Central Nervous System Disease, a premier Open Access publication dedicated to advancing the understanding of neurological disorders and their underlying mechanisms. Published by SAGE Publications Ltd, this esteemed journal has been serving the scientific community since 2009 and is committed to disseminating high-quality research that spans from clinical neurology to cellular and molecular neuroscience. With an impressive impact factor, the journal ranks within the top quartiles—Q2 in both Neurology and Clinical Neurology, and Q3 in Cellular and Molecular Neuroscience as of 2023. The journal's indexing in Scopus reflects its significant contribution to the field, being ranked #83 out of 400 in clinical neurology and #38 out of 97 in cellular and molecular neuroscience. This essential resource, based in the United States, is crucial for researchers, clinicians, and students looking to stay at the forefront of neurological science. By providing Open Access options, we ensure that groundbreaking research is readily available to a global audience, fostering collaboration and innovation in the study of central nervous system diseases.

NEUROLOGY INDIA, a reputable journal published by Wolters Kluwer Medknow Publications, serves as a pivotal resource in the field of neurology, focusing on clinical and research insights from India and beyond. Established in 1965, this journal has embraced a rich publishing history, converging its years of publication with the intention of fostering knowledge exchange among healthcare professionals, researchers, and students. With an ISSN of 0028-3886 and E-ISSN 1998-4022, it is indexed and ranked in Quartile 3 for both Neurology and Clinical Neurology categories as of 2023. While it does not operate as an open-access journal, it remains an essential platform for disseminating high-quality research, contributing significantly to the understanding of neurological diseases and treatment options. Operating out of Mumbai, India, NEUROLOGY INDIA is committed to bridging the gap in global neurology discourse, and it stands as an important reference for practitioners and scholars seeking to advance their expertise in this critical area of medicine.

SEMINARS IN NEUROLOGY is a leading journal in the field of neurology, published by THIEME MEDICAL PUBL INC. With its ISSN 0271-8235 and E-ISSN 1098-9021, this esteemed journal has been a vital resource for the neurology community since its inception in 1984. Covering critical advancements and contemporary issues in both neurology and clinical neurology, it holds a reputable position in the Q2 category for both disciplines as of 2023. The journal ranks #164 out of 400 in clinical neurology, indicating its significant contribution to the field, and is indexed in Scopus for robust academic exposure. SEMINARS IN NEUROLOGY offers a platform for authors to disseminate groundbreaking research and reviews, ultimately enhancing knowledge and practice in neurological sciences. With unrestricted access options, it seeks to engage researchers, practitioners, and students, fostering a comprehensive understanding of the complexities of neurological disorders and therapies.

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

European Journal of Paediatric Neurology, published by Elsevier Science Ltd, is a premier academic journal dedicated to advancing the field of paediatric neurology. With its ISSN 1090-3798 and E-ISSN 1532-2130, this journal serves as a vital resource for researchers, clinicians, and students alike, focusing on the latest findings and innovative treatments in paediatric neurological disorders. The journal has established itself as a leading publication in its field, achieving a Q1 classification in Pediatrics, Perinatology and Child Health, and holding a reputable Q2 status in Clinical Neurology as of 2023. Positioned within the top 88th percentile in Pediatrics and the 76th percentile in Clinical Neurology according to Scopus ranks, it publishes rigorous peer-reviewed articles that contribute significantly to clinical practice and research. Although not open access, the journal provides vital insights into the complexities of neurological conditions affecting the pediatric population, making it an essential tool for scholars and professionals striving to improve child health outcomes. With a publication trajectory spanning from 1997 to 2024, it continues to be at the forefront of paediatric neurological research, inspiring innovation and collaboration in the scientific community.

Stroke Research and Treatment is a premier Open Access journal published by HINDAWI LTD, dedicated to advancing the understanding and management of stroke and related neurological disorders. Since its inception in 2010, this journal has established itself as a valuable resource for researchers and clinicians in the field of neurology, providing a platform for high-quality, peer-reviewed articles that aim to improve patient outcomes and stimulate clinical practice innovations. With a 2023 Scopus ranking placing it in the Q3 category and a percentile ranking of 44th in clinical neurology, the journal is positioned to influence the ongoing discourse in stroke research. Stroke Research and Treatment embraces a global audience, with its editorial operations based in London, England. The journal's commitment to open access ensures that its content is freely available to all, promoting extensive dissemination and engagement in this critical field of study. Researchers, professionals, and students are encouraged to contribute their findings to this dynamic journal, fostering collaboration and knowledge sharing in the ongoing fight against stroke.